Rye Brook, NY (March 21, 2018) - Turning sorrow into action, The Harry T. Mangurian Jr. Foundation, whose namesake died from acute myeloid leukemia (AML), continues to fuel The Leukemia & Lymphoma Society’s (LLS) ambitious attack on this deadly blood cancer. Specifically, with the Foundation’s support, LLS is leading a paradigm shift to treating cancers with a precision medicine approach – the right d...
Rye Brook, NY - March 15, 2018 – One of the greatest competitors of all time, Michael Jordan, once said, “Talent wins games, but teamwork and intelligence win championships.” Today, The Leukemia & Lymphoma Society® (LLS) officially kicks off the 29th annual competitive fundraising campaign, Man & Woman of the Year®. In 80 communities across the country, a select group of individuals and their cam...
View multimedia release here. Rye Brook, N.Y. (March 13, 2018) – As breakthroughs in cancer treatments are occurring at an ever increasing rate, The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances. Through its significant investment in cancer research – more than $1.2 billion since its founding nearly 70 years ago – LL...
Rye Brook, NY – Jan. 8, 2018 - The Leukemia & Lymphoma Society (LLS), the world’s largest voluntary health organization dedicated to fighting blood cancer, announced today new funding for research programs in mantle cell lymphoma (MCL) treatment through a generous donation from The Sarah Cannon Fund at The HCA Foundation. Among the 72,000 new cases per year of non-Hodgkin lymphomas (NHLs), approximately 4,...
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: